Kalkulator od Bio Protocol do Evro
Enostavno pretvorite Bio Protocol v Evro z našim kalkulatorjem. Spoznajte razvoj pretvorbe in glavne ekvivalence med BIO in EUR.
Pretvornik kriptovalut
Bio Protocol v EUR — Tržni podatki
Tržna kapitalizacija
58,71 mio.€
24h obseg
25,58 mio.€
Maksimalna ponudba
3,32 mrd.
Ponudba v obtoku
3,32 mrd.
Tip
currency
Cena BIO/EUR - Bio Protocol/Euro
Cena Bio Protocol je naraščajoče
Vrednost Bio Protocol je 0,0273€. To pomeni, da boš za nakup 5 BIO moral plačati 0,1366€. Nasprotno, s 1,00€ boš lahko kupil skupno 36,58982803 BIO, medtem ko bi ti 50,00€ omogočil nakup 1829,49140139 BIO.
V zadnjih 7 dneh je cena Bio Protocol povečano za +10,88%. Medtem, v zadnjih 24 urah, se je cena spremenila za +8,19%.
Pretvorba BIO v EUR
| Količina | 12. 06. 2026, 02:13 |
|---|---|
| 0.5 BIO | 0,0137€ |
| 1 BIO | 0,0273€ |
| 2 BIO | 0,0547€ |
| 5 BIO | 0,1366€ |
| 10 BIO | 0,2733€ |
| 50 BIO | 1,37€ |
| 100 BIO | 2,73€ |
| 500 BIO | 13,67€ |
| 1000 BIO | 27,33€ |
Pretvorba EUR v BIO
| Količina | 12. 06. 2026, 02:13 |
|---|---|
| 0,5000€ | 0.01366500 BIO |
| 1,00€ | 0.02733000 BIO |
| 2,00€ | 0.05466000 BIO |
| 5,00€ | 0.13665000 BIO |
| 10,00€ | 0.27330000 BIO |
| 50,00€ | 1.36650000 BIO |
| 100,00€ | 2.73300000 BIO |
| 500,00€ | 13.66500000 BIO |
| 1.000,00€ | 27.33000000 BIO |
Kupite Bio Protocol na varen način
Registrirajte se na Bit2Me in dostopajte do najbolj zaupanja vredne platforme za izmenjavo kriptovalut, da varno kupite in prodate Bio Protocol.
Kaj je Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
